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Motor neurone disease/amyotrophic lateral sclerosis 
(MND/ALS) is a fatal neurodegenerative disease that 
requires special attention at the end-of-life, particularly 
because disability is relentlessly progressive and death 
generally occurs in a predictable fashion.1,2 In the absence 
of a cure, palliative care and advance care planning (ACP) 
are key management strategies.1,2 The quality of care pro-
vided throughout the illness profoundly influences the 
end-of-life care (EOLC).1–3 The ‘End of Life Care Strategy’ 
aims at promoting excellence in EOLC.3 The central aspect 
of this strategy concerns patients’ preference for place of 
death. There is little in the literature about enabling MND/
ALS patients to make choices about their EOLC, particu-
larly relating to the preferred place of death (PPD).
Honouring patient’s choice for PPD is important, and 
this can be achieved through ACP.2,3 The Preferred 
Priorities for Care (PPC) document is a patient-held 
dynamic record that can be used as an ACP tool to promote 
discussion and documentation of wishes, preferences and 
priorities for care in relation to end-of-life issues.3,4 The 
Preston MND care and research centre serving a popula-
tion of 1.6 million in North West England offers PPC doc-
ument to all MND/ALS patients.
We reviewed the case notes of patients who died in 
2012 and 2013 to investigate whether completion of PPC 
document affected actual place of death or hospital use 
towards end-of-life. There were a total of 99 deaths, of 
which 33 (33.3%) occurred in hospital. PPC document 
was completed by 52 patients (52.5%); 29 (55.8%) identi-
fied home as a PPD and the rest identified hospice/home 
(n = 11; 21.2%), hospice (n = 10; 19.2%) or nursing home 
(n = 2; 3.8%). None identified hospital as a PPD. The 
majority of patients completing the document (com-
pleters) died at home (n = 18; 34.6%) or hospice (n = 16; 
30.8%); 12 (23.1%) died in hospital and 6 (11.5%) died at 
nursing home. PPC document was not completed in 47 
cases (47.4%). Majority of those who did not complete 
(non-completers) the document died in hospital (n = 21; 
44.7%), while 16 (34%) died at home, 6 (12.8%) at nurs-
ing home, 3 (6.4%) at hospice and 1 (2.1%) while on holi-
day (Figure 1). A chi-squared test demonstrates statistically 
significant difference between whether patients com-
pleted the document and where they died (χ2(16) = 71.06, 
p < 0.001). Odds ratios indicate that non-completers were 
1.96 times more likely to die in hospital. In contrast, com-
pleters were 4.84 times more likely to die in a hospice.
The main reason for admission in both groups was res-
piratory failure/shortness of breath (12 non-completers; 6 
completers); 4 non-completers and none of the completers 
were admitted with general deterioration. Other causes for 
admission included falls, breakdown of care and other 
medical reasons. The major reason for non-completion of 
PPC document was reluctance or refusal by the patient to 
discuss EOLC issues (51%). Other reasons included late 
diagnosis, inability to make wishes known due to cogni-
tive impairment and unexpected deterioration.
Majority of people would prefer to die at home, but 
unfortunately, this is not the reality they experience.3 
Healthcare towards end-of-life places a major resource 
burden on the health service.3,5 A retrospective study of 
1600 hospitalisations in patients with MND/ALS demon-
strated prolonged and expensive admissions, a high in 
hospital mortality rate and few routine discharges.5 Most 
of our patients who completed the PPC document were 
Choosing the place of death:  
Empowering motor neurone disease/
amyotrophic lateral sclerosis patients in 
end-of-life care decision making
Suresh Kumar Chhetri1,2, Belinda Fay Bradley2, 
Pauline Callagher1, Robert Addison-Jones1, Wendy Bennett1, 
Joyce Gardham1, Amy Parkes1, Robert William Lea2 
and Tahir Majeed1
1 Preston MND Care and Research Centre, Department of Neurology, 
Royal Preston Hospital, Lancashire Teaching Hospitals NHS 
Foundation Trust, Preston, UK
2University of Central Lancashire, Preston, UK
Corresponding author:
Suresh Kumar Chhetri, Preston MND Care and Research Centre, 
Department of Neurology, Royal Preston Hospital, Lancashire Teaching 
Hospitals NHS Foundation Trust, Preston PR2 9HT, UK. 
Email: chhetri@doctors.org.uk
570412 PMJ0010.1177/0269216315570412Palliative MedicineChhetri et al.
research-article2015
Research Letter
668 Palliative Medicine 29(7) 
able to achieve their PPD. Completion of document was 
associated with significantly reduced hospital deaths and 
increased hospice deaths: 44.7% of non-completers died 
in hospital. This value is strikingly similar to MND/ALS 
deaths in hospitals (45.1%) in England.6 A significant pro-
portion of these patients could potentially be cared at 
home, if their care preferences are known. The PPC docu-
ment thus facilitates multi-agency collaborative working 
including involvement of specialist palliative care team 
and enables MND/ALS patients to die in their PPD. ACP 
has also been shown to yield positive experiences in car-
egivers of patients with MND/ALS and reduce grief 
related symptoms in the bereavement phase.2 Patients/
relatives feel empowered by participating in decisions 
about EOLC, and shared decision making is valued at the 
end-of-life.1–3
We demonstrate that the use of PPC document empow-
ers patients to gain control over their EOLC when dealing 
with an uncontrollable cruel illness, enables delivery of 
personalised care and reduces hospital admissions. EOLC 
should be discussed early and throughout the disease tra-
jectory as an integral part of holistic care in MND/ALS. 
The PPC document is commonly used in the field of oncol-
ogy but not in MND/ALS. Our study supports the view 
that PPC document should also be offered to MND/ALS 
patients as a standard of care.
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Figure 1. Actual place of death of patients who completed the PPC document (n = 52) as compared to those that did not (n = 47).
